These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 18767161)
41. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor. Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335 [TBL] [Abstract][Full Text] [Related]
42. Specificity of T-cell alloreactivity. Felix NJ; Allen PM Nat Rev Immunol; 2007 Dec; 7(12):942-53. PubMed ID: 18007679 [TBL] [Abstract][Full Text] [Related]
43. How TCRs bind MHCs, peptides, and coreceptors. Rudolph MG; Stanfield RL; Wilson IA Annu Rev Immunol; 2006; 24():419-66. PubMed ID: 16551255 [TBL] [Abstract][Full Text] [Related]
44. High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules. Moritz A; Anjanappa R; Wagner C; Bunk S; Hofmann M; Pszolla G; Saikia A; Garcia-Alai M; Meijers R; Rammensee HG; Springer S; Maurer D Sci Immunol; 2019 Jul; 4(37):. PubMed ID: 31324691 [TBL] [Abstract][Full Text] [Related]
45. Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor. Deng L; Langley RJ; Brown PH; Xu G; Teng L; Wang Q; Gonzales MI; Callender GG; Nishimura MI; Topalian SL; Mariuzza RA Nat Immunol; 2007 Apr; 8(4):398-408. PubMed ID: 17334368 [TBL] [Abstract][Full Text] [Related]
46. The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy. Donermeyer DL; Weber KS; Kranz DM; Allen PM J Immunol; 2006 Nov; 177(10):6911-9. PubMed ID: 17082606 [TBL] [Abstract][Full Text] [Related]
47. Molecular components of T-cell recognition. Jorgensen JL; Reay PA; Ehrich EW; Davis MM Annu Rev Immunol; 1992; 10():835-73. PubMed ID: 1591005 [TBL] [Abstract][Full Text] [Related]
48. A signal integration model of thymic selection and natural regulatory T cell commitment. Khailaie S; Robert PA; Toker A; Huehn J; Meyer-Hermann M J Immunol; 2014 Dec; 193(12):5983-96. PubMed ID: 25392533 [TBL] [Abstract][Full Text] [Related]
49. Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity. Brophy SE; Jones LL; Holler PD; Kranz DM Mol Immunol; 2007 Mar; 44(9):2184-94. PubMed ID: 17169430 [TBL] [Abstract][Full Text] [Related]
50. Structure-activity relationship of T-cell receptors based on alanine scanning. Narimatsu S; Yoshioka Y; Morishige T; Yao X; Tsunoda S; Tsutsumi Y; Nishimura MI; Mukai Y; Okada N; Nakagawa S Biochem Biophys Res Commun; 2011 Dec; 415(4):558-62. PubMed ID: 22079637 [TBL] [Abstract][Full Text] [Related]
51. T-cell receptor specificity maintained by altered thermodynamics. Madura F; Rizkallah PJ; Miles KM; Holland CJ; Bulek AM; Fuller A; Schauenburg AJ; Miles JJ; Liddy N; Sami M; Li Y; Hossain M; Baker BM; Jakobsen BK; Sewell AK; Cole DK J Biol Chem; 2013 Jun; 288(26):18766-75. PubMed ID: 23698002 [TBL] [Abstract][Full Text] [Related]
52. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. Li Y; Huang Y; Lue J; Quandt JA; Martin R; Mariuzza RA EMBO J; 2005 Sep; 24(17):2968-79. PubMed ID: 16079912 [TBL] [Abstract][Full Text] [Related]
53. An Engineered Switch in T Cell Receptor Specificity Leads to an Unusual but Functional Binding Geometry. Harris DT; Singh NK; Cai Q; Smith SN; Vander Kooi C; Procko E; Kranz DM; Baker BM Structure; 2016 Jul; 24(7):1142-1154. PubMed ID: 27238970 [TBL] [Abstract][Full Text] [Related]
54. Engineering higher affinity T cell receptors using a T cell display system. Chervin AS; Aggen DH; Raseman JM; Kranz DM J Immunol Methods; 2008 Dec; 339(2):175-84. PubMed ID: 18854190 [TBL] [Abstract][Full Text] [Related]
55. Is TCR/pMHC Affinity a Good Estimate of the T-cell Response? An Answer Based on Predictions From 12 Phenotypic Models. Gálvez J; Gálvez JJ; García-Peñarrubia P Front Immunol; 2019; 10():349. PubMed ID: 30886616 [TBL] [Abstract][Full Text] [Related]
56. TCR recognition of peptide/MHC class II complexes and superantigens. Sundberg EJ; Deng L; Mariuzza RA Semin Immunol; 2007 Aug; 19(4):262-71. PubMed ID: 17560120 [TBL] [Abstract][Full Text] [Related]
57. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493 [TBL] [Abstract][Full Text] [Related]
58. Human cytomegalovirus-specific T-cell receptor engineered for high affinity and soluble expression using mammalian cell display. Wagner EK; Qerqez AN; Stevens CA; Nguyen AW; Delidakis G; Maynard JA J Biol Chem; 2019 Apr; 294(15):5790-5804. PubMed ID: 30796163 [TBL] [Abstract][Full Text] [Related]
59. Low affinity interaction of peptide-MHC complexes with T cell receptors. Matsui K; Boniface JJ; Reay PA; Schild H; Fazekas de St Groth B; Davis MM Science; 1991 Dec; 254(5039):1788-91. PubMed ID: 1763329 [TBL] [Abstract][Full Text] [Related]
60. Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors. O'Herrin SM; Lebowitz MS; Bieler JG; al-Ramadi BK; Utz U; Bothwell AL; Schneck JP J Exp Med; 1997 Oct; 186(8):1333-45. PubMed ID: 9334373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]